Dan Smithey, PhD

Dan Smithey, PhD

President & CEO

Seran Bioscience

About me

Dr. Smithey is President, CEO and Co-founder of Seran. Over his 30-year career, his work has led to the successful development of several novel medicines, including Tucatinib (Tukysa(R)). Previously, Dr. Smithey led a team at Bend Research (now Lonza(R)) in the development of the spray-dried dispersion technology used today. Subsequently, Dr. Smithey co-founded Agere Pharmaceuticals, a specialty CDMO, acquired by Patheon in 2015. He is an inventor in over 50 patent and patent applications.
Registration Type
Exhibitor Booth Staff

Is member of

Seran Bioscience
Exhibitors
Seran Bioscience
Exhibitors
Seran Bioscience
Exhibitors
Seran Bioscience
Exhibitors
Seran Bioscience
Exhibitors

is attending

Scaling Spray Drying for Tomorrow’s Therapies to Ensure Supply Chain Resilience

Thursday, October 30, 2025 12:15 PM to 12:40 PM
Iris Duarte · Catalent

Bioavailability Enhancement Strategies for Targeted Protein Degraders

Thursday, October 30, 2025 12:15 PM to 12:40 PM
Hall 4.1 - 4.1L8
David O'Connell · PCI Pharma Services

The New Dynamics of U.S. Pharma: How Market Forces Are Redefining the Industry's Future

Tuesday, June 2, 2026 1:50 PM to 2:35 PM
Main Stage
Tom Sellig · Adare Pharma Solutions

Inside the FDA: What’s Happening Now and What’s Coming Next?

Tuesday, June 2, 2026 3:00 PM to 3:20 PM
Main Stage

FDA in Flux: Navigating the New Regulatory Landscape

Tuesday, June 2, 2026 4:20 PM to 5:00 PM
Main Stage
Gil Roth · PBOA - Pharma & Biopharma Outsourcing Association

Log in

See all the content and easy-to-use features by logging in or registering!